Market Analysis and Price Projections for the Drug NDC: 68084-0494
Introduction
The drug identified by the National Drug Code (NDC) 68084-0494 is associated with Benztropine Mesylate, a medication used as an adjunct in the therapy of all forms of parkinsonism and for controlling extrapyramidal disorders, except for tardive dyskinesia. Here, we will delve into the market analysis and price projections for this drug.
Market Context
The pharmaceutical market, particularly the segment involving neurologic and psychiatric medications, is dynamic and influenced by various factors such as regulatory changes, technological advancements, and patient needs.
Biopharma and Biotech Industry Growth
The biopharma and biotech industries are experiencing significant growth, with the biopharma market size estimated to be over $400 billion in 2024 and projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3]. This growth is driven by advancements in technological capabilities, evolving regulatory frameworks, and a shift towards patient-centered care.
Drug Specifics
Benztropine Mesylate
Benztropine Mesylate is available in various strengths, including 0.5 mg, 1 mg, and 2 mg tablets. It is distributed by American Health Packaging and manufactured by Par Pharmaceutical[1].
Packaging and Distribution
The drug is packaged in unit dose blisters, with different NDC codes corresponding to different strengths and package sizes. For example, the NDC 68084-381-01 corresponds to 0.5 mg tablets packaged in 100 unit doses[1].
Pricing Trends
General Pharmaceutical Pricing
Pharmaceutical prices, especially for specialty drugs, tend to increase over time. For instance, the overall trend for specialty pharmaceuticals has seen a price increase of around 3.8%[4].
Specific Pricing for Benztropine Mesylate
While specific pricing data for NDC 68084-0494 is not readily available, we can infer from similar products that prices are influenced by factors such as production costs, market demand, and regulatory changes.
Regulatory Environment
National Drug Code (NDC) and FDA Regulations
The NDC system, managed by the FDA, ensures that each drug product has a unique identifier. This system helps in tracking and managing drug products, including their pricing and distribution. The FDA's regulatory framework plays a crucial role in the approval and pricing of drugs, ensuring safety and efficacy[5].
Market Analysis
Demand and Supply
The demand for Benztropine Mesylate is driven by the prevalence of parkinsonism and other extrapyramidal disorders. As the population ages, the demand for such medications is likely to increase.
Competitive Landscape
The market for antiparkinsonian drugs is competitive, with several other medications available. However, Benztropine Mesylate has a specific niche due to its efficacy in controlling extrapyramidal symptoms.
Price Projections
Short-Term Projections
Given the general trend of pharmaceutical price increases, it is likely that the price of Benztropine Mesylate will rise in the short term. A conservative estimate would be an increase in line with the overall trend of 3.8% for specialty pharmaceuticals[4].
Long-Term Projections
In the long term, the price of Benztropine Mesylate could be influenced by several factors, including:
- Technological Advancements: Innovations in drug development and manufacturing could reduce costs.
- Regulatory Changes: Evolving regulatory frameworks might impact pricing strategies.
- Market Competition: New entrants in the market could lead to competitive pricing.
Key Takeaways
- Market Growth: The biopharma and biotech industries are growing rapidly, driven by technological advancements and regulatory changes.
- Drug Specifics: Benztropine Mesylate is used for parkinsonism and extrapyramidal disorders, with various strengths and packaging options.
- Pricing Trends: Pharmaceutical prices tend to increase, with a projected short-term increase of around 3.8%.
- Regulatory Environment: The FDA's NDC system and regulatory framework are crucial for drug pricing and management.
- Market Analysis: Demand is driven by the prevalence of parkinsonism, and the market is competitive.
FAQs
1. What is Benztropine Mesylate used for?
Benztropine Mesylate is used as an adjunct in the therapy of all forms of parkinsonism and for controlling extrapyramidal disorders, except for tardive dyskinesia.
2. How is Benztropine Mesylate packaged?
It is packaged in unit dose blisters, available in strengths of 0.5 mg, 1 mg, and 2 mg tablets.
3. What is the expected price trend for Benztropine Mesylate?
The price is likely to increase in line with the overall trend of 3.8% for specialty pharmaceuticals in the short term.
4. What factors influence the price of Benztropine Mesylate?
Factors include production costs, market demand, regulatory changes, technological advancements, and market competition.
5. How does the FDA's NDC system impact drug pricing?
The NDC system ensures each drug product has a unique identifier, helping in tracking and managing drug products, including their pricing and distribution.
Sources
- DailyMed: BENZTROPINE MESYLATE tablet - DailyMed
- American Health Packaging: NDC Updates
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
- DrugPatentWatch: Latest drug prices and trends for NDC 72819-0160
- FDA: National Drug Code Database Background Information
